New Launch20 Aug 2025, 10:39 am
Dr. Lal PathLabs Pioneers AI Integration in Cancer Diagnosis in India
AI Summary
Dr. Lal PathLabs has become the first laboratory in India to adopt a deep learning-based AI module to detect lymph node metastasis, including micrometastasis, in cancer cases. This cutting-edge technology, validated in collaboration with Qritive, was showcased at USCAP 2025. Accurate identification of cancer spread to lymph nodes is vital in determining the stage and treatment path for patients. The AI tool, QiAl Lymph Node Dx, changes the diagnostic landscape by using deep learning to quickly and accurately spot cancer cells on digital slides. This advancement leads to earlier, more accurate diagnoses—improving treatment decisions for patients.
Key Highlights
- 100% Sensitivity & Negative Predictive Value: The AI model detected all metastatic cases with no false negatives.
- Enhanced Accuracy: Even single cancer cell metastasis was detected and later confirmed using immunohistochemistry.
- Tumour Agnostic: The AI module has been validated across multiple cancer types, demonstrating its versatility and broad clinical applicability.
- Clinical Benefit: Earlier, more accurate diagnoses—improving treatment decisions for patients.
- Collaboration: Validated in collaboration with Qritive, a breakthrough AI solution developer in Singapore.